Psychedelic substances have been demonstrated to interact with a variety of neurotransmitter pathways, including those involving serotonin, acetylcholine, norepinephrine, and dopamine. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of psychedelic substances. Further, experts believe that psychedelics, at appropriate doses, can be used to address some of the serious psychological implications associated with the COVID-19 pandemic.
To order this 250+ page report, which features 120+ figures and 135+ tables, please visit this link
The over USD 6.5 billion (by 2030) financial opportunity within the psychedelic therapeutics market has been analyzed across the following segments:
Target Disease Indication
Anxiety and Depression
Trauma
Pain Disorder
Sleep related Disorder
Origin of Psychedelic Substance
Natural
Synthetic
Type of Psychedelic Substance
Gamma-hydroxybutyrate
Ketamine
MDMA
Psilocybin
Route of Administration
Oral
Intranasal
Sublingual
Key Geographies
North America
Europe
Asia-Pacific
The Global Psychedelic Therapeutics Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:
Celon Pharma
iX Biopharma
MAPS Public Benefit
MindMed
Janssen Pharmaceuticals
Jazz Pharmaceutical
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape: Psychedelic Therapeutics
5. Company Profiles
6. Clinical Trial Analysis
7. Clinical Trial Site Analysis
9. Key Opinion Leader (KOL) Analysis
8. Academic Grants Analysis
10. Partnerships and Collaborations
11. Mergers and Acquisitions
12. Market Forecast and Opportunity Analysis
13. Concluding Remarks
14. Executive Insights
15. Appendix 1: Tabulated Data
16. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]